Macrocyclic Lactones Block Melanoma Growth, Metastases Development and Potentiate Activity of Anti–BRAF V600 Inhibitors
Clinical Skin Cancer · 2016
DOI: 10.1016/j.clsc.2016.05.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Skin Cancer, 2016. Verfasst von Franck Gallardo und 6 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Gallardo, F., Teiti, I., Rochaix, P., Demilly, E., Jullien, D., Mariamé, B., & Tilkin-Mariamé, A. (2016). Macrocyclic Lactones Block Melanoma Growth, Metastases Development and Potentiate Activity of Anti–BRAF V600 Inhibitors. Clinical Skin Cancer. https://doi.org/10.1016/j.clsc.2016.05.001
Vancouver
Gallardo F, Teiti I, Rochaix P, Demilly E, Jullien D, Mariamé B, et al. Macrocyclic Lactones Block Melanoma Growth, Metastases Development and Potentiate Activity of Anti–BRAF V600 Inhibitors. Clinical Skin Cancer. 2016. doi:10.1016/j.clsc.2016.05.001
BibTeX
@article{Gallardo2016,
author = {Gallardo, Franck and Teiti, Iotefa and Rochaix, Philippe and Demilly, Eloise and Jullien, Denis and Mariamé, Bernard and Tilkin-Mariamé, Anne-Françoise},
title = {Macrocyclic Lactones Block Melanoma Growth, Metastases Development and Potentiate Activity of Anti–BRAF V600 Inhibitors},
journal = {Clinical Skin Cancer},
year = {2016},
doi = {10.1016/j.clsc.2016.05.001}
}
EUVIMED